Neurol. praxi. 2017;18(2):98-102 | DOI: 10.36290/neu.2017.070

Intensice care in patients with Guillain-Barré syndrome

MUDr. Petr Hon
Neurologická klinika, FN Ostrava

Acute polyradiculoneuritis – Guillain – Barré syndrome (GBS) is the most frequent peripheral nerves illnes, requiring neurointensive

care. About 30 % patients have respiratory dysfunction and need ventilatory support. Specific for this disease is vegetative

nerves dysfunction with hemodynamic lability, gastrointestinal complication, need for long lasting mechanical ventilation in

full consciousness patient. Early recognition of respiratory failure, adequate intensive care in unite dispensing with possibility of

complex care is the basic condition of succesfull therapy.

Keywords: Guillain-Barré syndrome, neurointensive care, respiratory failure, GBS therapy

Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hon P. Intensice care in patients with Guillain-Barré syndrome. Neurol. praxi. 2017;18(2):98-102. doi: 10.36290/neu.2017.070.
Download citation

References

  1. Ali MI, Ferna'ndez-Pe'rez RE, Pendem S, Brown DR, Wijdicks EF, Gajic O. Mechanical ventilation in patients with Guillain-Barre' syndrome. Respir Care 2006; 51(12): 1403-1407.
  2. Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol. 1990; 27(Suppl): S7-12. Go to original source... Go to PubMed...
  3. Bhagat H, Dash HH, Chauhan RS, Khanna P, Bithal PK. Intensive care management of Guillain-Barre syndrome: a retrospective outcome study and review of literature. J Neuroanaesthesiol Crit Care 2014; 1: 188-197. Go to original source...
  4. Cibulčík F. Polyradiculoneuritis Guillain Barré. Neurol. praxi 2016; 17(1): 7-11 Go to original source...
  5. Dimachkie MM, Barohn TJ. Current treatment options in neurology 2013; 15: 338-349. Go to original source... Go to PubMed...
  6. Ehler E, Derďáková M, Latta J, Mrklovský M. Akutní polyradikuloneuritida - diferenciální diagnostika. Neurol. praxi 2011; 12(3): 181-187.
  7. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doom PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2014; 137: 33-43. Go to original source... Go to PubMed...
  8. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2010 Jun 16. CD002063. Go to original source... Go to PubMed...
  9. Hughes RAC, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007; 130: 2245-2257. Go to original source... Go to PubMed...
  10. Kennedy C, Magee CC. Therapeutic plasmapheresis, in Singh AK, et al. (eds.), Core concepts in dialysis and continuous therapies, DOI 10.1007/978-1-4899-7657-4_20, Springer Science+Business Media, LLC 2016. Go to original source...
  11. Leeuwen Nikki van, Hester F, Lingsma, Ann M. Vanrolleghem, Miriam CJM, Sturkenboom Pieter A, van Doorn, Ewout W. Steyerberg, Bart C. Jacobs, hospital admissions, transfers and costs of Guillain-Barré syndrome. PLoS ONE 11(2): e0143837. Go to original source...
  12. Lizarraga AA, Lizarraga KJ, Benatar M. Getting rid of weakness in the ICU: an updated approach to the acute management of myasthenia gravis and Guillain-Barré syndrome. Semin Neurol 2016; 36: 615-624. Go to original source... Go to PubMed...
  13. Meena A, Padmaja D, Naveen K, Rukmini M Sheik A, Rupam B. Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome. Journal of Critical Care 29 2014; 219-223. Go to original source... Go to PubMed...
  14. Mc Daneld LM, Fields JD, Bourdette DN, Bhardwaj A. Immunomodulatory therapies in neurologic critical care, neurocrit. Care 2010; 12: 132-143. Go to original source... Go to PubMed...
  15. Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J Neurosci Rural Pract 2017; 8: 68-73. Go to original source... Go to PubMed...
  16. Orlikowski D, Prigent H, Sharshar T. Respiratory dysfunction in guillain-barré syndrome, Neurocrit Care 2004; 1: 415. Go to original source... Go to PubMed...
  17. Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012 Jul 11. 7: CD001798. Go to original source... Go to PubMed...
  18. Ropper AH. ICU management of acute inflammatory - post-infectious polyneuropathy. In Ropper AH, Kenndy SK, eds. Neurological and neurosurgical intensive care. 2nd ed. Rockville, Md.: Aspen, 1988: 253-268.
  19. Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011; 76(8): 701-704. Go to original source... Go to PubMed...
  20. Van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med. 1992; 326(17): 1123-1129. Go to original source... Go to PubMed...
  21. Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013; 80: 1650-1654. Go to original source... Go to PubMed...
  22. Witsch J, Galldiks N, Bender A. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol 2013; 260: 1367-1374. Go to original source... Go to PubMed...
  23. Ying Wang, Hong-Liang Zhang Xiujuan Wu Jie Zhu. Complications of Guillain-Barré syndrome. Expert Review of Clinical Immunology Volume 12, 2016. Go to original source... Go to PubMed...
  24. Wongsurakiat P, Pierson DJ, Rubenfeld GD. Changing pattern of ventilator settings patients without acute lung injury: changes over 11 years in a single institution. Chest 2004; 126(4): 1281-1291. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.